Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2009 1
2011 1
2012 3
2015 2
2016 1
2017 2
2018 4
2019 2
2020 5
2021 8
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous T cell lymphoma.
Dummer R, Vermeer MH, Scarisbrick JJ, Kim YH, Stonesifer C, Tensen CP, Geskin LJ, Quaglino P, Ramelyte E. Dummer R, et al. Among authors: scarisbrick jj. Nat Rev Dis Primers. 2021 Aug 26;7(1):61. doi: 10.1038/s41572-021-00296-9. Nat Rev Dis Primers. 2021. PMID: 34446710 Review.
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data.
Horwitz SM, Scarisbrick JJ, Dummer R, Whittaker S, Duvic M, Kim YH, Quaglino P, Zinzani PL, Bechter O, Eradat H, Pinter-Brown L, Akilov OE, Geskin L, Sanches JA, Ortiz-Romero PL, Weichenthal M, Fisher DC, Walewski J, Trotman J, Taylor K, Dalle S, Stadler R, Lisano J, Bunn V, Little M, Prince HM. Horwitz SM, et al. Among authors: scarisbrick jj. Blood Adv. 2021 Dec 14;5(23):5098-5106. doi: 10.1182/bloodadvances.2021004710. Blood Adv. 2021. PMID: 34507350 Free PMC article. Clinical Trial.
Update on skin directed therapies in mycosis fungoides.
Lovgren ML, Scarisbrick JJ. Lovgren ML, et al. Among authors: scarisbrick jj. Chin Clin Oncol. 2019 Feb;8(1):7. doi: 10.21037/cco.2018.11.03. Epub 2018 Nov 28. Chin Clin Oncol. 2019. PMID: 30525757 Free article. Review.
New drugs in cutaneous T-cell lymphomas.
Scarisbrick JJ. Scarisbrick JJ. Curr Opin Oncol. 2016 Sep;28(5):384-9. doi: 10.1097/CCO.0000000000000311. Curr Opin Oncol. 2016. PMID: 27390044 Review.
Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.
Scarisbrick JJ, Hodak E, Bagot M, Stranzenbach R, Stadler R, Ortiz-Romero PL, Papadavid E, Evison F, Knobler R, Quaglino P, Vermeer MH. Scarisbrick JJ, et al. Eur J Cancer. 2018 Apr;93:47-56. doi: 10.1016/j.ejca.2018.01.076. Epub 2018 Feb 21. Eur J Cancer. 2018. PMID: 29477101 Free article. Review.
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome.
Quaglino P, Fava P, Pileri A, Grandi V, Sanlorenzo M, Panasiti V, Guglielmo A, Alberti-Violetti S, Novelli M, Astrua C, Rubatto M, Tonella L, Berti E, Pimpinelli N, Osella Abate S, Fierro MT, Vermeer M, Scarisbrick JJ, Ribero S. Quaglino P, et al. Among authors: scarisbrick jj. J Invest Dermatol. 2021 Mar;141(3):484-495. doi: 10.1016/j.jid.2020.07.026. Epub 2020 Nov 5. J Invest Dermatol. 2021. PMID: 33162051 Free article. Review.
36 results